The present invention relates to metered dose inhalers for delivery of medicament to patients via aerosolization of the medicament, and related cleaning methods and devices.
Delivery of drugs via metered dose inhalers is well known for treating various conditions such as asthma. Typically, a metered dose inhaler includes a canister containing a pressurized supply of medicament that is mated to an inhaler actuator assembly. Typically, the supply of medicament is triggered by displacing a hollow valve stem of the canister toward the main body of the canister. This releases a metered portion of the medicament (e.g., a predetermined metered amount) into the inhaler actuator assembly. The significant pressure differential between the canister pressure and the atmosphere results in the released material being propelled through the inhaler actuator assembly. More particularly, the released material is typically directed through a very small nozzle orifice (or “nozzle”) that aerosolizes the spray. This aerosolized spray is then inhaled by the patient so as to be preferentially deposited in the lungs.
The nozzle orifice is an important determinant of the resultant aerosol droplet size and size distribution. A smaller orifice tends to produce a finer spray, which is typically more therapeutically effective. However, a small nozzle orifice also creates a constriction in the flow path, which creates some backpressure that is communicated along the valve stem. The presence of this backpressure causes the flow of material through the valve stem to be slower than it otherwise would be. Because of the slower flow rate, there is an increased possibility of having some medicament deposit on the interior of the valve stem. Build up of the medicament inside the valve stem can undesirably lead to sporadic break off of the material, which can result in clogging of the downstream nozzle orifice, or lead to undesirable biological contamination of the device, or affect dose uniformity.
The extent of deposition inside the valve stem depends on the medicament formulation, valve stem material properties, and on the design of the inhaler actuator assembly. Conventional metered dose inhalers for asthma may not experience significant build up of material in the valve stem due to the formulations used. Thus, while patients arc typically instructed to clean the inhaler using various techniques, no known cleaning approach addresses cleaning of the inside of the canister valve stem. However, as metered dose inhalers are adapted for use with other formulations, such as formulations with larger molecule sizes (e.g., macromolecules) and/or different chemistries, internal valve stem build up is believed to become more of a consideration for proper operation.
Thus, there remains a need for alternative approaches to using and/or cleaning metered dose inhalers, advantageously approaches that allow the interior of the valve stein to be easily cleaned.
Various embodiments of the present invention are intended to allow a canister of pressurized medicament to be removed, fully or partially, from a metered dose inhaler actuation assembly and thereafter subjected to a cleaning actuation to dislodge undesirable material that can be present on the interior of the canister's valve stem. During the cleaning actuation, backpressure in the valve stem is substantially reduced and/or eliminated by routing the resulting flow to atmosphere along an improved flow path. The improved flow path in some embodiments, has no constrictions less than about 75% of the size of the valve stem's outlet port, and advantageously no constrictions less than the size of the valve stem's outlet port. Thus, the backpressure experienced by the valve stem is greatly reduced versus that experienced during a normal dosing actuation. As a result, the flow rate of medicament through the valve stem during the cleaning actuation can be higher than during a normal dosing actuation, allowing the built-up material to be dislodged during the cleaning actuation.
In one embodiment, a method of cleaning at least a portion of a metered dose inhaler comprises: joining a canister to a body; the canister having a pressurized supply of medicament therein and a hollow outlet stem terminating at an outlet port; the canister operative to output a metered amount of the medicament via the outlet port in response to being triggered: the outlet port having a first size; the body having a passage therethrough; triggering the canister to fire by displacing the canister toward the body passage so as to thereby spray medicament from the canister into the passage to generate a pressurized exhaust from the passage; routing the exhaust from the passage to atmosphere such that the exhaust encounters no constrictions smaller than about 75% of the first size. The exhaust can be routed directly to atmosphere or can be routed through a collection chamber associated with the body.
Other aspects of various embodiments of a related inventive device and other related methods are also disclosed in the following description. The various aspects can be used alone or in any combination, as is desired.
The present invention relates to metered dose inhalers. Referring to
The inhaler assembly 20 can take a wide variety of forms known in the art. One exemplary inhaler assembly 20 is a generally L-shaped body as shown in
In exemplary embodiments of the present invention, the canister 30 is removed from inhaler assembly 20 after several firings, joined to a separate cleaning body 50 for cleaning of the interior of valve stem 40, and then rejoined to the inhaler assembly 20. One embodiment of a cleaning body 50 is shown in
The medicament can be administered to the patient by initially mating the canister 30 to the inhaler assembly 20 in any conventional fashion. The canister 30 is then triggered to supply the medicament 5 to the aerosolizing portions of the assembly 20, and the aerosolized medicament is inhaled by the patient. A single “charge” of medicament 5 can correspond to a dose, or a dose can comprise multiple charges taken in short succession. This dosing regimen is advantageously repeated multiple times over a period of time. For example, the dosing regimen can be repeated three times a day for several days. When the dosing regimen exceeds a threshold, the valve stem 40 is cleaned. This threshold can be set as a given number of actuations of the canister 30, or a given amount of time, or a combination thereof. Or, a cleaning cycle can be initiated if the patient suspects some problem with the inhaler 10.
To clean the valve stem 40, the canister 30 is removed from the inhaler assembly 20 and joined to the cleaning body 50. To do this, the valve stem 40 is inserted into the upper portion 62 of cleaning body central passage 60 until the valve stem 40 abuts against shoulder 66. The canister 30 is pressed toward the cleaning body 50, so that the valve stem 40 presses against shoulder 66. During this action, the combination of the cleaning body 50 and the canister 30 can be supported in a variety of ways. For example, the lower surface 54 of cleaning body 50 can be supported by two spread fingers of one hand and the thumb of the hand placed over the flat base 38 of canister 30 (which is facing away from cleaning body 50). As the canister 30 is pressed, the valve stem 40 is forced to move relative to the canister main body 32, until the valve stem 40 relatively retracts to the firing position.
Movement of the valve stem 40 to the firing position causes a charge of pressurized medicament to be released into the valve stem 40, where it rapidly expands and flows out stem outlet port 46 due to the relative pressure differential. The medicament 5 flows directly from the stem outlet port 46 into lower portion 64 of passage 60, though the lower portion 64, and out the passage 60 as an exhaust 68. As can be appreciated, this exhaust 68 is vented directly to atmosphere in this embodiment because passage 60 opens directly to atmosphere. As Such, exhaust 68 does not encounter any constrictions less than the size of valve stem outlet port 46 before being reaching ambient atmosphere. Because of this, it is believed that that significant backpressure is not generated in the valve stem 40, and the resulting flow rate through the valve stem 40 is maximized. It should be noted that this flow rate is higher than that experienced during normal inhalation activation. The higher flow rate tends to strip away any undesired deposits that could have formed inside bore 44 of valve stem 40. Further, any stripped material is simply carried away to atmosphere in exhaust 68, and therefore cannot result in blockage of the nozzle orifice of the inhaler assembly 20. In most situations, only one firing of the canister 30 will be appropriate for complete cleaning, although multiple firings can be appropriate in some situations. After the cleaning firing(s), the canister 30 is removed from the cleaning body 50 and re-mated to the inhaler assembly 20. If desired, the exterior 42 of valve stem 40 can be striped or otherwise cleaned prior to re-mating with the inhaler assembly 20. Also, the inhaler assembly 20 can be cleaned using any appropriate technique while the canister 30 is unmated therefrom. The inhaler 10 is then ready for additional use.
In other embodiments, the cleaning body 50 can be more complex. For example, a more complex cleaning body 50 is shown in
The cleaning body 50 embodiment of
It has been assumed above that cleaning body 50 does not substantially longitudinally overlap canister main body 32. However, in some embodiments, a portion of the cleaning body 50 can longitudinally overlap a significant length of the canister main body 32. For example, the cleaning body 50 of
The discussion above has assumed that the flow path 100 from the valve stem outlet port 46 reaches ambient atmosphere without encountering any constrictions smaller than the cross-sectional size of the valve stem interior. However, slightly smaller constrictions can be present in some embodiments of the present invention. For example, the lower portion 64 of passage 60 call have a cross-section that is 75% of the cross-sectional size of the valve stem interior. Advantageously, this size is larger, such as 80%, 85%. 90%, or 95%, with larger size ratios being preferred. It is believed that a size ratio of ≧100% is more advantageous, but constrictions sized between 100% and about 75% (inclusive) cannot generate significant backpressure, and the flow rates of the medicament through the valve stem 40 can be maintained at desired levels. These sizes are in stark contrast to the typical 1%-5% sizes of the nozzle orifices typically employed.
The discussion above has assumed that the cleaning body 50 is directly supported by the user's hand; however, such is not required in all embodiments. In some embodiments, the cleaning body 50 can be supported by a suitable fixture, which in turn can be handheld or placed on a suitable surface during the cleaning actuation. Indeed, as shown in
Several tests have been run to examine the effect of using a cleaning body 50, and the results indicate that following a cleaning regimen that encourages periodic cleaning of the valve stem interior will lead to better performance. Each of the tests used a pressurized insulin medicament in the canister 30, with the formulation being a relatively high strength suspension formulation. The weight of the medicament sprayed from the canister (“shot weight”) was measured for each actuation, with a ten second wait between each actuation. A substantially similar inhaler assembly 20 was used for each test, and three canisters were tested at each test condition.
Test A used a five minute wait between sets of three actuations, without a cleaning regimen. The inhaler was found to be clogged after approximately twenty-seven actuations of the first canister. The second canister caused clogging after approximately forty-five actuations. The third canister did not cause clogging after one hundred twenty actuations, but showed a marked variation in shot weight around sixty actuations and again around eighty actuations.
Test B used a sixty minute wait between sets of three actuations, without a cleaning regimen. The inhaler was found to be clogged after approximately thirty-six actuations of the first canister. The other two canisters caused clogging after approximately eighty-seven actuations each.
Test C used a five minute wait between sets of three actuations (similar to Test A), with a cleaning actuation using a cleaning button 50 after every thirty actuations. The inhaler was found to be clogged after approximately ninety-two actuations for the first canister. The second canister caused clogging after approximately one hundred eighteen actuations. The other canister did not clog or show a significant drop off in shot weight until the canister was emptied after approximately one hundred forty actuations.
Test D was similar to Test C, but the cleaning cycle was changed to be a cleaning actuation using a cleaning button 50 after every twenty actuations. None of the three canisters caused clogging or showed a significant drop off in shot weight through approximately one hundred forty actuations (at which point the canisters were emptied).
The instances of clogging during the testing outlined above appear to be the result of build up of material on the inside of the valve stem, and subsequent break off of the agglomerated material. It is believed that the broken off material moves downstream, probably during that “shot” but possibly during a subsequent shot, to block a downstream constriction, such as the nozzle orifice.
Based on the above, it is clear that subjecting the canisters 30 to a cleaning regimen using a cleaning button can improve performance of an inhaler 10. It is believed that the appropriate frequency of the cleaning regimen will vary based on a number of factors, including medicament composition, valve stem material, valve stem size, nozzle orifice size, and the like. Nevertheless, a cleaning frequency of approximately every ten to twenty actuations is believed appropriate for most situations.
The present invention can be carried out in other specific ways than those herein set forth without departing from the scope and essential characteristics of the invention. Further, the various aspects of the disclosed device and method can be used alone or in any combination, as is desired. The disclosed embodiments are, therefore, to be considered in all respects as illustrative and not restrictive, and all changes coming within the meaning and equivalency range of the appended claims are intended to be embraced therein.
This application claims the benefit of U.S. Provisional Patent Application No. 60/887,422, filed Jan. 31, 2007, which is hereby incorporated by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
60887422 | Jan 2007 | US |